Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ca2fe5a1e9022aa0323cbb48d30f5e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2003-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2007-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c935369ff43fe5dc7827292b6b7250a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bd328c79ed05d675e41a70493559c20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a982e81b4fde5d74fe7ea8a4bd7eae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9534fc4d70b598b9ed5ff631f4544232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83813d03f962d19433f8bb95a82e750b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6839eee3eeeb8d1881dad98177239616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb29d1d62dc08cbce1f3d7a5574887f |
publicationDate |
2007-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7253272-B2 |
titleOfInvention |
Gene BRCC-2 and diagnostic and therapeutic uses thereof |
abstract |
A gene that is a modulator of tumor growth and metastasis in certain cancer types is provided. This gene and corresponding polypeptide have diagnostic and therapeutic application for detecting and treating cancers that involve expression of BRCC2 such as breast cancer and lung cancer. |
priorityDate |
2001-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |